// App-Quantinova.ai

1269-332 : DOES SEVERITY OF LEFT VENTRICULAR REMODELING INFLUENCE THE RELATION BETWEEN MYOCARDIAL VIABILITY AND SURVIVAL WITH MEDICAL OR SURGICAL THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION?

Researchers

Presenter

  • Robert O. Bonow

Principal Investigators

  • Serenella Castelvecchio

  • Julio Panza

  • Daniel Berman

  • Eric Velazquez

  • Robert Michler

  • Lilin She

  • Thomas Holly

  • Patrice Desvigne Nickens

  • Dragana Kosevic

  • Miroslaw Rajda

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left ventricular dysfunction

  • Coronary Artery Disease

  • Ischemic cardiomyopathy

  • Heart muscle disease

Biomarkers

  • Cartilage oligomeric matrix protein

Drug/Treatment

  • Dobutamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved